Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma (SSAT042)
|ClinicalTrials.gov Identifier: NCT01330342|
Recruitment Status : Unknown
Verified June 2012 by St Stephens Aids Trust.
Recruitment status was: Recruiting
First Posted : April 6, 2011
Last Update Posted : June 11, 2012
|Condition or disease|
The study team will take two or three tubes of blood on three occasions during the course of chemotherapy. The total amount of blood required for this research project is 64mL (approximately 4 tablespoons).
This will allow better understanding of the changes that take place in the blood and the HIV virus itself. It is hoped that this will provide new insights that may aid the understanding and treatment of HIV patients with lymphoma.
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Observational Model:||Case Control|
|Official Title:||Evolution of Cellular and Viral Resistance in HIV-infected Patients With Lymphoma|
|Study Start Date :||May 2011|
|Estimated Primary Completion Date :||May 2014|
|Estimated Study Completion Date :||May 2014|
HIV patients without lymphoma
HIV-infected subjects on cART without a diagnosis of lymphoma
HIV patients with lymphoma
HIV seropositive individuals with lymphoma
- Development of multi-drug resistance (in terms of expression of transmembrane transporters and their transcriptional regulators) in HIV-infected patients with lymphoma. [ Time Frame: 3 years ]
- Development of mutations in the HIV genome that may confer resistance to future treatment for HIV. [ Time Frame: 3 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01330342
|Contact: Marta Boffito, Dr||020 3315 firstname.lastname@example.org|
|St Stephen's Centre||Recruiting|
|London, United Kingdom, SW10 9NH|
|Contact: Marta Boffito, Dr email@example.com|
|Principal Investigator: Marta Boffito, Dr|
|Principal Investigator:||Marta Boffito, Dr||St Stephen's AIDS Trust|